Candel Therapeutics (NASDAQ:CADL – Get Free Report) and Dyadic International (NASDAQ:DYAI – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends. Valuation and Earnings This table compares Candel […]
Candel Therapeutics (NASDAQ:CADL – Get Free Report) and Gamida Cell (NASDAQ:GMDA – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, risk, analyst recommendations, earnings and institutional ownership. Institutional & Insider Ownership 18.2% of Candel […]
Candel Therapeutics, Inc. (NASDAQ:CADL – Get Free Report) saw a large increase in short interest during the month of July. As of July 31st, there was short interest totalling 172,100 shares, an increase of 8.6% from the July 15th total of 158,500 shares. Based on an average daily volume of 19,600 shares, the short-interest ratio […]
Candel Therapeutics, Inc. (NASDAQ:CADL – Get Rating) shot up 6.1% during mid-day trading on Tuesday . The stock traded as high as $1.75 and last traded at $1.74. 3,145 shares changed hands during mid-day trading, a decline of 90% from the average session volume of 32,608 shares. The stock had previously closed at $1.64. Wall […]
Candel Therapeutics, Inc. (NASDAQ:CADL – Get Rating) saw a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 134,500 shares, an increase of 163.2% from the April 15th total of 51,100 shares. Based on an average daily volume of 29,600 shares, the short-interest ratio is […]